Compare BIOA & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIOA | POET |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United States | Canada |
| Employees | 64 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 856.3M | 959.0M |
| IPO Year | N/A | 2008 |
| Metric | BIOA | POET |
|---|---|---|
| Price | $21.13 | $6.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $51.80 | N/A |
| AVG Volume (30 Days) | 448.5K | ★ 6.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,939.08 |
| Revenue Next Year | $898.47 | $710.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.88 | $3.10 |
| 52 Week High | $24.00 | $9.41 |
| Indicator | BIOA | POET |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 50.78 |
| Support Level | $18.62 | $5.05 |
| Resistance Level | $22.25 | $7.42 |
| Average True Range (ATR) | 1.42 | 0.63 |
| MACD | -0.13 | 0.05 |
| Stochastic Oscillator | 67.45 | 31.61 |
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.